Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „marketing“
Suchtreffer
Begriffe & Kennungen
Abilify Maintena · 4.8 · Prolactin In clinical trials for the approved indications and in post-marketing data both increase and decreas
Eintrag öffnenAbilify Maintena · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAbilify Maintena · 4.8 · The ADRs listed under the frequency “not known” were reported during post-marketing use.
Eintrag öffnenAbilify Maintena · 4.8 · The ADRs listed under the frequency “not known” were reported during post-marketing use.
Eintrag öffnenAbiraterone Mylan · 4.8 · Adverse reactions observed during clinical studies and post-marketing experience are listed below by frequency
Eintrag öffnenAbiraterone Mylan · 4.8 · Table 1: Adverse reactions identified in clinical studies and post-marketing System Organ Class Adverse reacti
Eintrag öffnenAbraxane · 4.8 · Eye disorders There have been rare reports during post-marketing surveillance of reduced visual acuity due to
Eintrag öffnenActos · 4.8 · Description of selected adverse reactions 1 Postmarketing reports of hypersensitivity reactions in patients tr
Eintrag öffnenActraphane · 4.8 · * see Description of selected adverse reactions † ADR from postmarketing sources.
Eintrag öffnenActraphane · 4.8 · * see Description of selected adverse reactions † ADR from postmarketing sources.
Eintrag öffnenActraphane · 4.8 · Based on post-marketing sources and clinical trials, the frequency, type and severity of adverse reactions obs
Eintrag öffnenActraphane · 4.8 · Based on post-marketing sources and clinical trials, the frequency, type and severity of adverse reactions obs
Eintrag öffnenActraphane · 4.8 · Based on post-marketing sources and clinical trials, the frequency, type and severity of adverse reactions obs
Eintrag öffnenActraphane · 4.8 · Based on post-marketing sources and clinical trials, the frequency, type and severity of adverse reactions obs
Eintrag öffnenActrapid · 4.8 · * see Description of selected adverse reactions † ADR from postmarketing sources.
Eintrag öffnenActrapid · 4.8 · Based on post-marketing sources and clinical trials, the frequency, type and severity of adverse reactions obs
Eintrag öffnenActrapid · 4.8 · Based on post-marketing sources and clinical trials, the frequency, type and severity of adverse reactions obs
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · Post-marketing study in paediatric patients (H6D-JE-TD01) Safety data were collected during an observational p
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · Post-marketing study in paediatric patients (H6D-JE-TD01) Safety data were collected during an observational p
Eintrag öffnenAdjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.8 · From post-marketing experience with AS03-containing vaccines containing 3.75 microgram HA derived from A/Calif
Eintrag öffnen